POSTGRADUATE RESEARCH INSTITUTE cyprushost
 
 
  About PRI
  Research at PRI
  Publications
  Deferiprone
  ICOC Conference
  RAHMS Conference
  Contact PRI

Several PRI studies have been published in a number of international journals including:

ArzneimForschDrugRes

Biomarkers and Environment
 
Drugs of Today

Journal of Radioanalytical and Nuclear Chemistry

Lancet
 
SOSTE Notiziario

Transfusion Science



 
 
Other publications by PRI members

back to PRI publications
 
Publications by Katerina Pattichis:
K. Pattichis, M. Kajbaf & J.W. Gorrod (1991)
The in vitro metabolism of Mifentidine and two of its derivatives by different species. Progress in Pharmacology and Clinical Pharmacology 8:31-40

M. Kajbaf, J.H. Lamb, S. Naylor, K. Pattichis & J.W. Gorrod (1991)
Identification of metabolites derived form the H2-receptor antagonist Mifentidine using Tandem Mass Spectrometry. Analytica Chimica Acta 247 (2) 151-159.

M. Kajbaf, M. Jahanshahi, K. Pattichis, J.H. Lamb, J.W. Gorrod & S. Naylor (1992). Rapid and efficient purification of Cimetropium bromide and Mifentidine drug metabolite mixtures derived from microsomal incubates for analysis by Mass Spectrometry. Journal of Chromatography 575: 75-85.

K. Pattichis, J. Jarman, V. Glover, M. Sandler, G. Aislaitner & J.W. Gorrod (1992). Red wine as a migraine trigger: Examination of its effects on 14C-5-hydroxytryptamine release from platelets.In: "5-Hydroxytryptamine Mechanisms in Primary Headaches" Ch. 32, pp 242-246, J. Olesen & P.R. Saxena (Eds.), Raven Press Ltd, New York.

K. Pattichis, L.L. Louca, J. Jarman, M. Sandler & V. Glover (1993)
Phenolic substances in red wine and release of platelet 5-hydroxytryptamine. Lancet 341:1104

K. Pattichis, L.L. Louca, M. Kajbaf & J.W. Gorrod (1993)
Mifentidine, a formamidine, is metabolised to a urea; a new metabolic pathway. Medical Science Research 21: 747-748

R. Hering, T. Catarci, K. Pattichis & V. Glover (1993)
5-HT in migraine patients with medication-induced headache.
Cephalalgia 13: 410-412

K. Pattichis, L.L. Louca, J. Jarman & V. Glover (1994)
Red wine but not white wine can cause a rise in human whole blood 5-Hydroxytryptamine level. Medical Science Research 22: 381-382

V. Glover, K. Pattichis, J. Jarman, R. Peatfield & M. Sandler (1994)
How does red wine cause migraine?In: "New Advances in Headache Research" 3 Ch 25 pp 145-150, C.F. Rose (Ed.), Smith Gordon & Co Ltd, London.

K. Pattichis, L.L. Louca & V. Glover (1994)
Quantitation of soluble superoxide dismutase in rat striata, based on the inhibition of nitrite formation from hydroxylammmonium chloride. Analytical Biochemistry 221: 428-431


K. Pattichis, L.L. Louca, J. Jarman, M. Sandler & V. Glover (1995)
5-Hydroxytryptamine release from platelets by different red wines: implications for migraine.European Journal of Pharmacology (Environmental Toxicology and Pharmacology Section) 292:173-177

K. Pattichis & L.L. Louca (1995)
Histamine, histamine H2-receptors and antagonists, gastric acid secretion and peptic ulcers: an overview. Drug Metabolism and Drug Interactions 12:1-36.

K. Pattichis, L.L. Louca, A. Clow & V. Glover (1995)
Effects of pergolide, (-)-deprenyl and thioridazine on soluble SOD, catalase and glutathione peroxidase in rat striata. Medical Science Research 23: 733-735.

J. Jarman, K. Pattichis, R. Peatfiled, V. Glover & M. Sandler (1996)
Red wine-induced release of [C-14]5-hydroxytryptamine from platelets of migraine patients and controls. Cephalalgia 16: 41-43

C. Di Salvo, L.L. Louca, K. Pattichis, J. Hooper, R.K. Walesby (1996)
Does activated neutrophil depletion on bypass by leukocyte filtration reduce myocardial damage? A preliminary report. Journal of Cardiovascular Surgery (Torino) 37 (6 Suppl 1) 93-100.

K. Pattichis, M. Kajbaf & J.W. Gorrod (1997)
In vitro studies on the metabolic fate of Mifentidine, a novel histamine H2-receptor antagonist. European Journal of Drug Metabolism and Pharmacokinetics 22:155-164.

G.J. Kontoghiorghes, K. Pattichis, M. Hadjigavriel & A. Kolnagou (2000). Transfusional iron overload and chelation therapy with defereoxamine and deferiprone (L1). Transfusion Science 23: 211-223

Kontoghiorghes G.J., Pattichis K., Neocleous K., Kolnagou A. (2004)
The design and development of deferiprone (L1) and other iron chelators for clinical use: targeting methods and application prospects. Current Medicinal Chemistry 11: 2161-2183.


 

 
 

Best viewed with
Internet Explorer
at 800 x 600 or higher
Last update:
24 January 2006

 
 
POSTGRADUATE RESEARCH INSTITUTE Science, Technology, Environment and Medicine
3 Ammochostou Street, CY-3021 Limassol, Cyprus
Postal address: P.O. Box 51342, CY-3504 Limassol, Cyprus
Tel: +357 25 734 615, Fax: +357 25 395 926, Email:
kontoghiorghes.g.j@pri.ac.cy
About PRIResearch at PRI  |  Publications  |  Deferiprone  |  Conferences  |  Sponsors  |  Contact PRI
 
  Copyright © 2002-2006 Postgraduate Research Institute

cyprushost

Designed by LabWell Research Laboratories